the aid library

LIST OPTIONS

Filter

3546

Prevención de la transmisión maternoinfantil del virus de la hepatitis B. Directrices sobre la profilaxis con antivirales en el embarazo
recommended

Organización Mundial de la Salud OMS; UNICEF OPS (2020) C_WHO

En estas directrices se actualiza la sección de recomendaciones sobre la prevención de la transmisión maternoinfantil de las Directrices para la prevención, la atención y el tratamiento de la infección crónica por el virus de la hepatitis B, publicadas por la OMS en el 2015, y se centra la at... more

Download (1197)

View PDF (1210)

Project monitoring and evaluation (M&E) guide

International Federation of Red Cross And Red Crescent Societies (2011) C1

The guide is divided into 3 sections —the first focuses on the conceptual framework for M&E; the second focuses on six key steps for M&E; and further, the appendix provides additional tools, resources, and projects for M&E. With a comprehensive breakdown of the important approaches as well as a ch... more

Download (345)

View PDF (365)

Una nueva agenda para la salud mental en las Américas. Informe de la Comisión de Alto Nivel sobre Salud Mental y COVID-19 de la Organización Panamericana de la Salud

Pan American Health Organisation PAHO (2024) C_WHO

Las necesidades de salud mental insatisfechas en la Región de las Américas son una de las principales causas de morbimortalidad, y tienen enormes consecuencias sociales, económicas y para la salud. La pandemia de COVID-19 ha exacerbado la crisis de la salud mental en la Región, por lo que se nec... more

Download (513)

View PDF (733)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (950)

View PDF (1373)

Education and Training. Technical Series on Safer Primary Care

World Health Organization WHO (2016) C_WHO

Good primary care may lead to fewer avoidable hospitalizations, but unsafe primary care can cause avoidable illness and injury, leading to unnecessary hospitalizations, and in some cases, disability and even death.Implementing system changes and practices are crucial to improve safety at all levels ... more

Download (315)

View PDF (677)

Strengthening capacity for noncommunicable disease implementation research in the WHO European Region (2019)

World Health Organization WHO, Regional Office of Europe (2019) C_WHO

Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-informed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving ... more

Download (549)

View PDF (1390)

Risk Communication and Community Engagement Considerations: Ebola Response in Democratic Republic of the Congo

World Health Organization WHO (2018) C_WHO

Overview: Risk communication and community engagement are essential for any disease outbreak response. This is particularly critical during outbreaks of Ebola which may create fear in the public and frontline responders alike due to severe presentation of symptoms, misunderstanding of the causes of ... more

Download (286)

View PDF (428)

Dietary salt intake survey in the Republic of Moldova, 2016

World Health OrganizationEurope (2018) C_WHO

High salt consumption is an important determinant of high blood pressure and reducing it would improve health outcomes by lowering cardiovascular disease and therefore death rates. Reducing salt intake has been identified as one of the most effective public health measures and is one of the leading ... more

Download (350)

View PDF (471)

Inclusión de las personas mayores en la planificación para emergencias: Perspectivas durante y después de la pandemia de COVID-19

World Health Organisation (WHO) (2023) C_WHO

En la Región de las Américas, las poblaciones están envejeciendo y se está experimentando una rápida transición demográfica. El índice de envejecimiento, que refleja el tamaño de los grupos de mayor edad por 100 en comparación con los menores de 15 años, demuestra claramente el aumento de... more

Download (744)

View PDF (1073)

Global Monitoring of Disease Outbreak Preparedness: Preventing the Next Pandemic

Harvard Global Health Institute (2018) C1

This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec... more

Download (381)

View PDF (628)

Working with Children in Unstable Situations: Principles and Concepts to Guide Psychosocial Responses

United Nations International Children's Emergency Fund (UNICEF) (2003)

This document is designed to provide UNICEF staff and UNICEF partner staff with principles and concepts that can assist them to respond to the psychosocial needs of children in natural disasters and social emergencies such as armed conflict and other forms of violence. It aims to introduce humanitar... more

Download (1252)

View PDF (2534)

WHO Level II household survey to measure access to and use of medicines in Ghana

Daniel Kojo Arhinful Ministry of Health, Ghana (2011) C1

This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio... more

Download (248)

View PDF (371)

National school meals and nutrition strategy 2017–2022

Ministry of Health, Kenya (2018) C1

This strategy takes into account the policies formulated by sectors with cross-cutting interests in school meals, such as education, health, social protection and agriculture.The strategy further complements the provisions of the National School Health Policy and the asso... more

Download (292)

View PDF (353)

Consideraciones sobre las medidas de salud pública relacionadas con las escuelas para los grupos en situación de vulnerabilidad en el contexto de la COVID-19

Pan American Health Organisation PAHO (2021) C_WHO

n este documento de orientación se abordan las las consecuencias sociales, económicas y en materia de salud de las medidas adoptadas para controlar la pandemia en relación con el cierre de las escuelas, así como los elementos que deben tenerse en cuenta al reabrir y cerrar las escuelas, haciendo... more

Download (274)

View PDF (299)

Refugiados y migrantes en Ecuador - Reporte de situación (Diciembre 2020)

R4V (2020) CC

Las fronteras con Colombia y Perú se mantuvieron cerradas y parecería que esta medida se extendería los primeros meses del año 2021. Los contagios por COVID-19 incrementaron de manera sostenida durante el mes de diciembre. Para evitar aglomeraciones y una saturación en el sistema de salud, el G... more

Download (345)

View PDF (348)

Plan Estratégico Colombia Hacia el Fin de la Tuberculosis, 2016 –2025 (Colombia Strategic Plan Towards eliminateTB, 2016 –2025)

Organizacion Panamerica de la Salud Ministerio de Salud (2016) CC

El Plan Estratégico Colombia Hacia el Fin de la Tuberculosis, 2016 –2025 es un instrumento para la gestión de los programas en los nivelesnacional y local en su objetivo de respondera los compromisos adquiridos por los países, para adoptarla Estrategia Mundial Fin de la Tuberculosi... more

Download (305)

View PDF (362)

Hypertension - Screening, Diagnosis, Assessment, and Management of Primary Hypertension in Adultd in India

Ministry of Health & Family Welfare India Government of India (2017) CC

Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ... more

Download (374)

View PDF (478)

The 2014 Myanmar Population and Housing Census: Thematic Report on Mortality

The Republic of the Union of Myanmar (2016) C1

Census Report Volume 4-B
In the 2014 Census, early-age mortality was measured from the responses to two simple retrospective questions on childbearing addressed to ever-married women aged 15 and over. These questions referred to how many live children they had ever given birth to, and how many ... more

Download (363)

View PDF (618)

Humanitarian Action for Children: Myanmar

UN Children's Fund UNICEF (2020) C_UNICEF

Over 1 million people, including an estimated 450,000 children, are affected by Myanmar’s decade-long conflict and are increasingly vulnerable to gender-based violence, exploitation, abuse, detention and trafficking. Community transmission of coronavirus disease 2019 (COVID-19) is increasing in... more

Prevención de la transmisión maternoinfantil del virus de la hepatitis B. Directrices sobre la profilaxis con antivirales en el embarazo recommended

Prevención de la transmisión maternoinfantil del virus de la hepatitis B. Directrices sobre la profilaxis con antivirales en el embarazo
recommended